Interventionalists treating congenital heart lesions are constantly faced with challenging
therapeutic decisions, often without randomized trials to support one approach over the …

Coarctation of the aorta (CoA) occurs in 0.04% of the population and accounts for
approximately 10% of lesions in adults with congenital heart disease (ACHD). It can occur …

BACKGROUND: Covered stent (CS) use for the transcatheter treatment of coarctation of the
aorta (COA) was first described over 20 years ago. The covered Cheatham-platinum stent …

It is fundamental to the human psyche to strive for the things we don't have. This need has
driven innovation and technological advancement for millennia. Occasionally, however, this …

Objective Stenting of coarctation of aorta with covered or uncovered stents is the accepted
modality of treatment in older children and adults. The indications which mandate the use of …

Objectives This study aimed to describe the safety and efficacy of covered stents in patients
with coarctation of aorta (CoA) for immediate and long-term follow-up. Background Covered …

Background: Long-term outcome data of stent-implantation for coarctation of the aorta are
limited. We report up to 5 years of postimplant follow-up in patients enrolled into the COAST …

In our center, 102 patients with native or postoperative aortic coarctation were treated with
stent implantation. Fifty-four patients were studied with computed tomography (CT) scan …

Coarctation of the aorta can be managed in different ways depending upon the age of
presentation, anatomical details of the coarctation, the aortic arch anatomy, and whether the …

Objectives: We describe our complete experience with covered stent implantation for aortic
coarctation including short‐to medium‐term outcomes. Background: Coarctation of the aorta …